Literature DB >> 21242333

Protein microarray analysis of mammary epithelial cells from obese and nonobese women at high risk for breast cancer: feasibility data.

Patrick G Pilie1, Catherine Ibarra-Drendall, Michelle M Troch, Gloria Broadwater, William T Barry, Emanuel F Petricoin, Julia D Wulfkuhle, Lance A Liotta, Siya Lem, Joseph C Baker, April Stouder, Anne C Ford, Lee G Wilke, Carola M Zalles, Priya Mehta, Jamila Williams, Melanie Shivraj, Zuowei Su, Joseph Geradts, Dihua Yu, Victoria L Seewaldt.   

Abstract

BACKGROUND: Obesity is a well-established risk factor for cancer, accounting for up to 20% of cancer deaths in women. Studies of women with breast cancer have shown obesity to be associated with an increased risk of dying from breast cancer and increased risk of developing distant metastasis. While previous studies have focused on differences in circulating hormone levels as a cause for increased breast cancer incidence in postmenopausal women, few studies have focused on potential differences in the protein expression patterns of mammary epithelial cells obtained from obese versus nonobese women.
METHODS: Protein expression was assessed by reverse-phase protein microarray in mammary epithelial cells from 31 random periareolar fine needle aspirations performed on 26 high-risk women.
RESULTS: In this pilot and exploratory study, vimentin (unadjusted P=0.028) expression was significantly different between obese and nonobese women.
CONCLUSIONS: Vimentin is integral both to adipocyte structure and function and to the epithelial-to-mesenchymal transition needed for cancer cell metastasis. Further research is needed to confirm this finding and determine the possible effects of the adipocyte microenvironment on the initiation and progression of breast cancer in high-risk women. IMPACT: Differential protein expression patterns obtained from a future expanded study may serve to elaborate the underlying pathology of breast cancer initiation and progression in obese women and identify potential biomarkers of response to preventative interventions such as dietary changes and exercise. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21242333      PMCID: PMC3051011          DOI: 10.1158/1055-9965.EPI-10-0847

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  24 in total

Review 1.  Protein microarrays: meeting analytical challenges for clinical applications.

Authors:  Lance A Liotta; Virginia Espina; Arpita I Mehta; Valerie Calvert; Kevin Rosenblatt; David Geho; Peter J Munson; Lynn Young; Julia Wulfkuhle; Emanuel F Petricoin
Journal:  Cancer Cell       Date:  2003-04       Impact factor: 31.743

2.  Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization.

Authors:  Puneeth Iyengar; Terry P Combs; Shalin J Shah; Valérie Gouon-Evans; Jeffrey W Pollard; Chris Albanese; Louise Flanagan; Martin P Tenniswood; Chandan Guha; Michael P Lisanti; Richard G Pestell; Philipp E Scherer
Journal:  Oncogene       Date:  2003-09-25       Impact factor: 9.867

3.  Arachidonic acid promotes epithelial-to-mesenchymal-like transition in mammary epithelial cells MCF10A.

Authors:  Raul Martinez-Orozco; Napoleon Navarro-Tito; Adriana Soto-Guzman; Luis Castro-Sanchez; Eduardo Perez Salazar
Journal:  Eur J Cell Biol       Date:  2010-03-06       Impact factor: 4.492

4.  Vimentin is a functional partner of hormone sensitive lipase and facilitates lipolysis.

Authors:  Wen-Jun Shen; Shailja Patel; John E Eriksson; Fredric B Kraemer
Journal:  J Proteome Res       Date:  2010-04-05       Impact factor: 4.466

5.  Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model.

Authors:  C J Fabian; B F Kimler; C M Zalles; J R Klemp; S Kamel; S Zeiger; M S Mayo
Journal:  J Natl Cancer Inst       Date:  2000-08-02       Impact factor: 13.506

6.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

7.  Functional protein network activation mapping reveals new potential molecular drug targets for poor prognosis pediatric BCP-ALL.

Authors:  Benedetta Accordi; Virginia Espina; Marco Giordan; Amy VanMeter; Gloria Milani; Luisa Galla; Maria Ruzzene; Manuela Sciro; Luca Trentin; Ruggero De Maria; Geertruy te Kronnie; Emanuel Petricoin; Lance Liotta; Giuseppe Basso
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

8.  Reproducibility of random periareolar fine needle aspiration in a multi-institutional Cancer and Leukemia Group B (CALGB) cross-sectional study.

Authors:  Catherine Ibarra-Drendall; Lee G Wilke; Carola Zalles; Victoria Scott; Laura E Archer; Siya Lem; Lisa D Yee; Joanne Lester; Swati Kulkarni; Christine Murekeyisoni; Marie Wood; Karen Wilson; Judy Garber; Carleen Gentry; April Stouder; Gloria Broadwater; Joseph C Baker; Shauna N Vasilatos; Elizabeth Owens; Sarah Rabiner; Abbey C Barron; Victoria L Seewaldt
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-04-21       Impact factor: 4.254

Review 9.  Leptin-induced adipose apoptosis: Implications for body weight regulation.

Authors:  P S Gullicksen; M A Della-Fera; C A Baile
Journal:  Apoptosis       Date:  2003-08       Impact factor: 4.677

10.  Effect of family history, obesity and exercise on breast cancer risk among postmenopausal women.

Authors:  Catherine L Carpenter; Ronald K Ross; Annlia Paganini-Hill; Leslie Bernstein
Journal:  Int J Cancer       Date:  2003-08-10       Impact factor: 7.396

View more
  7 in total

1.  Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials.

Authors:  Reena S Cecchini; Joseph P Costantino; Jane A Cauley; Walter M Cronin; D Lawrence Wickerham; Stephanie R Land; Joel L Weissfeld; Norman Wolmark
Journal:  Cancer Prev Res (Phila)       Date:  2012-02-07

2.  Pilot and feasibility study: prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways.

Authors:  Catherine Ibarra-Drendall; Michelle M Troch; William T Barry; Gloria Broadwater; Emanuel F Petricoin; Julia Wulfkuhle; Lance A Liotta; Siya Lem; Joseph C Baker; Anne C Ford; Lee G Wilke; Carola Zalles; Nicole M Kuderer; Abigail W Hoffman; Melanie Shivraj; Priya Mehta; Jamila Williams; Nora Tolbert; Laurie W Lee; Patrick G Pilie; Dihua Yu; Victoria L Seewaldt
Journal:  Breast Cancer Res Treat       Date:  2011-06-07       Impact factor: 4.872

Review 3.  Tumor mechanics and metabolic dysfunction.

Authors:  Jason C Tung; J Matthew Barnes; Shraddha R Desai; Christopher Sistrunk; Matthew W Conklin; Pepper Schedin; Kevin W Eliceiri; Patricia J Keely; Victoria L Seewaldt; Valerie M Weaver
Journal:  Free Radic Biol Med       Date:  2014-12-19       Impact factor: 7.376

Review 4.  Weighing the Risk: effects of Obesity on the Mammary Gland and Breast Cancer Risk.

Authors:  Lauren E Hillers-Ziemer; Lisa M Arendt
Journal:  J Mammary Gland Biol Neoplasia       Date:  2020-06-09       Impact factor: 2.673

Review 5.  Targeting the therapeutic effects of exercise on redox-sensitive mechanisms in the vascular endothelium during tumor progression.

Authors:  Gretchen Wolff; Michal Toborek
Journal:  IUBMB Life       Date:  2013-06-12       Impact factor: 3.885

6.  Dietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor models.

Authors:  Sarah M Dunlap; Lucia J Chiao; Leticia Nogueira; Jerry Usary; Charles M Perou; Lyuba Varticovski; Stephen D Hursting
Journal:  Cancer Prev Res (Phila)       Date:  2012-05-15

7.  Comparison of Random Periareolar Fine Needle Aspirate versus Ductal Lavage for Risk Assessment and Prevention of Breast Cancer.

Authors:  Abigail Hoffman; Rod Pellenberg; Catherine Ibarra Drendall; Victoria Seewaldt
Journal:  Curr Breast Cancer Rep       Date:  2012-06-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.